Technical Analysis for NVCN - Neovasc Inc.

Grade Last Price % Change Price Change
grade C 0.4899 -0.95% 0.00
NVCN closed down 0.95 percent on Friday, May 17, 2019, on 32 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical NVCN trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Boomer Buy Setup Bullish Swing Setup -0.95%
Bollinger Band Squeeze Range Contraction -0.95%
Narrow Range Bar Range Contraction -0.95%
NR7 Range Contraction -0.95%

Older signals for NVCN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Medicine Medical Specialties Medical Devices Circulatory System Interventional Cardiology Cardiac Surgery Cardiovascular Products Cardiovascular Edwards Lifesciences Heart Valve Valvular Heart Disease
Is NVCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.9
52 Week Low 0.372
Average Volume 1,891,724
200-Day Moving Average 1.449
50-Day Moving Average 0.4712
20-Day Moving Average 0.5027
10-Day Moving Average 0.5093
Average True Range 0.0449
ADX 33.84
+DI 31.6318
-DI 13.479
Chandelier Exit (Long, 3 ATRs ) 0.5253
Chandelier Exit (Short, 3 ATRs ) 0.5547
Upper Bollinger Band 0.543
Lower Bollinger Band 0.4624
Percent B (%b) 0.34
BandWidth 16.03342
MACD Line 0.0056
MACD Signal Line 0.0083
MACD Histogram -0.0027
Fundamentals Value
Market Cap 38.66 Million
Num Shares 78.9 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -7.00
Price-to-Sales 13.79
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.52
Resistance 3 (R3) 0.52 0.51 0.51
Resistance 2 (R2) 0.51 0.50 0.51 0.51
Resistance 1 (R1) 0.50 0.50 0.49 0.50 0.51
Pivot Point 0.49 0.49 0.49 0.49 0.49
Support 1 (S1) 0.48 0.48 0.47 0.48 0.47
Support 2 (S2) 0.47 0.48 0.47 0.47
Support 3 (S3) 0.46 0.47 0.46
Support 4 (S4) 0.46